Asbestos exposure

Our plain-English summary of Asbestos exposure, by D.L. Davis (Journal of the National Cancer Institute, 1992).

The study

• Author: D.L. Davis
• Journal: Journal of the National Cancer Institute
• Published: 1992;84(7):537-8
• Type of article: Comment, Letter
• Read it: PubMed · Publisher

In plain English

This item was a letter to the editor, not an original study. The author commented on an earlier brief report in the same journal by Neugut and colleagues. That report was a case-control study comparing asbestos exposure in 410 patients with that in 509 control subjects. As the author described it, it found an elevated risk of colorectal neoplasia or adenomatous polyps among people with a history of significant asbestos exposure. Neugut and colleagues had excluded two of their 12 case subjects as unlikely to have workplace exposure: a man who had been a merchant marine for 22 years, and a teacher. The author argued that both could have had significant workplace exposures, and that excluding them produced an underestimate of the true risk and reduced the study's power. The author pointed to an earlier pooling of occupational studies of asbestos and gastrointestinal cancer. In that review, fewer than half of the negative studies had a power greater than 0.8 to detect a relative risk of 2.5. The author concluded that consistency across studies and biologic plausibility were demonstrated for the association, and urged wider use of meta-analysis.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: letter to the editor (correspondence) commenting on another group's published case-control study; no new data
• Who was studied: No population of its own. The letter discusses the case-control study by Neugut et al., which compared 410 patients with 509 control subjects.
• Exposure: Asbestos exposure, specifically a history of significant asbestos exposure as judged in the Neugut et al. study. The letter focuses on two excluded case subjects: a man who had been a merchant marine for 22 years, and a teacher. No fiber type is named in the letter text.
• Main results:
  • The author reported that Neugut et al. excluded two men from their 12 case subjects as unlikely to have workplace exposure.
  • The author argued that these two men could have had significant workplace exposures.
  • The author argued that excluding the two probably exposed persons from the 12 cases led to an underestimate of the true risk of colorectal neoplasia from asbestos exposure.
  • The author cited an earlier pooling of occupational studies of asbestos and gastrointestinal cancer (another study, not this letter). In that pooling, fewer than half of the negative studies had a power greater than 0.8 to detect a relative risk of 2.5.
  • The author argued that meta-analysis has considerable promise for studies of environmental and occupational exposures.
• The authors' conclusion: The author concluded that both consistency of the effect across studies and biologic plausibility were demonstrated for the association of colorectal neoplasia with asbestos exposure.

Topics

The National Library of Medicine indexes this study under subjects our site covers: Colon cancer.

Medical terms in this study, explained in our Lexicon: Asbestos Exposure.

Related studies

• Malignant peritoneal mesothelioma giving rise to multiple intestinal polyps — F.G. Mayall, A.R. Gibbs (1991)
• Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence — W.P. Ceelen, M.F. Flessner (2010)
• Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis — L.H. Iversen, P.C. Rasmussen, et al. (2013)
• Thymidylate synthase: a critical target for cancer chemotherapy — M.G. Rose, M.P. Farrell, et al. (2002)
• The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy — B. Moran, T. Cecil, et al. (2015)
• Raltitrexed: current clinical status and future directions — E. Van Cutsem, D. Cunningham, et al. (2002)

Browse more research in Journal of the National Cancer Institute, or return to medical research.